Mechanisms of nitric oxide synthase uncoupling in endotoxin-induced acute lung injury

Role of asymmetric dimethylarginine

Shruti Sharma, Anita Smith, Sanjiv Kumar, Saurabh Aggarwal, Imran Rehmani, Connie Snead, Cynthia Harmon, Jeffery Fineman, David J Fulton, John D. Catravas, Stephen Matthew Black

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Acute lung injury (ALI) is associated with severe alterations in lung structure and function and is characterized by hypoxemia, pulmonary edema, low lung compliance and widespread capillary leakage. Asymmetric dimethylarginine (ADMA), a known cardiovascular risk factor, has been linked to endothelial dysfunction and the pathogenesis of a number of cardiovascular diseases. However, the role of ADMA in the pathogenesis of ALI is less clear. ADMA is metabolized via hydrolytic degradation to l-citrulline and dimethylamine by the enzyme, dimethylarginine dimethylaminohydrolase (DDAH). Recent studies suggest that lipopolysaccharide (LPS) markedly increases the level of ADMA and decreases DDAH activity in endothelial cells. Thus, the purpose of this study was to determine if alterations in the ADMA/DDAH pathway contribute to the development of ALI initiated by LPS-exposure in mice. Our data demonstrate that LPS exposure significantly increases ADMA levels and this correlates with a decrease in DDAH activity but not protein levels of either DDAH I or DDAH II isoforms. Further, we found that the increase in ADMA levels cause an early decrease in nitric oxide (NOx) and a significant increase in both NO synthase (NOS)-derived superoxide and total nitrated lung proteins. Finally, we found that decreasing peroxynitrite levels with either uric acid or Manganese (III) tetrakis (1-methyl-4-pyridyl) porphyrin (MnTymPyp) significantly attenuated the lung leak associated with LPS-exposure in mice suggesting a key role for protein nitration in the progression of ALI. In conclusion, this is the first study that suggests a role of the ADMA/DDAH pathway during the development of ALI in mice and that ADMA may be a novel therapeutic biomarker to ascertain the risk for development of ALI.

Original languageEnglish (US)
Pages (from-to)182-190
Number of pages9
JournalVascular Pharmacology
Volume52
Issue number5-6
DOIs
StatePublished - May 1 2010

Fingerprint

Acute Lung Injury
Endotoxins
Nitric Oxide Synthase
Lipopolysaccharides
Lung
Lung Compliance
N,N-dimethylarginine
Citrulline
Proteins
Peroxynitrous Acid
Porphyrins
Pulmonary Edema
Manganese
dimethylargininase
Uric Acid
Superoxides
Nitric Oxide
Protein Isoforms
Cardiovascular Diseases
Endothelial Cells

Keywords

  • Arginine metabolism
  • Nitration
  • Superoxide

ASJC Scopus subject areas

  • Pharmacology
  • Molecular Medicine
  • Physiology

Cite this

Mechanisms of nitric oxide synthase uncoupling in endotoxin-induced acute lung injury : Role of asymmetric dimethylarginine. / Sharma, Shruti; Smith, Anita; Kumar, Sanjiv; Aggarwal, Saurabh; Rehmani, Imran; Snead, Connie; Harmon, Cynthia; Fineman, Jeffery; Fulton, David J; Catravas, John D.; Black, Stephen Matthew.

In: Vascular Pharmacology, Vol. 52, No. 5-6, 01.05.2010, p. 182-190.

Research output: Contribution to journalArticle

Sharma, Shruti ; Smith, Anita ; Kumar, Sanjiv ; Aggarwal, Saurabh ; Rehmani, Imran ; Snead, Connie ; Harmon, Cynthia ; Fineman, Jeffery ; Fulton, David J ; Catravas, John D. ; Black, Stephen Matthew. / Mechanisms of nitric oxide synthase uncoupling in endotoxin-induced acute lung injury : Role of asymmetric dimethylarginine. In: Vascular Pharmacology. 2010 ; Vol. 52, No. 5-6. pp. 182-190.
@article{d2b33e5b5d1c4b3ba674638e9042f590,
title = "Mechanisms of nitric oxide synthase uncoupling in endotoxin-induced acute lung injury: Role of asymmetric dimethylarginine",
abstract = "Acute lung injury (ALI) is associated with severe alterations in lung structure and function and is characterized by hypoxemia, pulmonary edema, low lung compliance and widespread capillary leakage. Asymmetric dimethylarginine (ADMA), a known cardiovascular risk factor, has been linked to endothelial dysfunction and the pathogenesis of a number of cardiovascular diseases. However, the role of ADMA in the pathogenesis of ALI is less clear. ADMA is metabolized via hydrolytic degradation to l-citrulline and dimethylamine by the enzyme, dimethylarginine dimethylaminohydrolase (DDAH). Recent studies suggest that lipopolysaccharide (LPS) markedly increases the level of ADMA and decreases DDAH activity in endothelial cells. Thus, the purpose of this study was to determine if alterations in the ADMA/DDAH pathway contribute to the development of ALI initiated by LPS-exposure in mice. Our data demonstrate that LPS exposure significantly increases ADMA levels and this correlates with a decrease in DDAH activity but not protein levels of either DDAH I or DDAH II isoforms. Further, we found that the increase in ADMA levels cause an early decrease in nitric oxide (NOx) and a significant increase in both NO synthase (NOS)-derived superoxide and total nitrated lung proteins. Finally, we found that decreasing peroxynitrite levels with either uric acid or Manganese (III) tetrakis (1-methyl-4-pyridyl) porphyrin (MnTymPyp) significantly attenuated the lung leak associated with LPS-exposure in mice suggesting a key role for protein nitration in the progression of ALI. In conclusion, this is the first study that suggests a role of the ADMA/DDAH pathway during the development of ALI in mice and that ADMA may be a novel therapeutic biomarker to ascertain the risk for development of ALI.",
keywords = "Arginine metabolism, Nitration, Superoxide",
author = "Shruti Sharma and Anita Smith and Sanjiv Kumar and Saurabh Aggarwal and Imran Rehmani and Connie Snead and Cynthia Harmon and Jeffery Fineman and Fulton, {David J} and Catravas, {John D.} and Black, {Stephen Matthew}",
year = "2010",
month = "5",
day = "1",
doi = "10.1016/j.vph.2009.11.010",
language = "English (US)",
volume = "52",
pages = "182--190",
journal = "Vascular Pharmacology",
issn = "1537-1891",
publisher = "Elsevier Inc.",
number = "5-6",

}

TY - JOUR

T1 - Mechanisms of nitric oxide synthase uncoupling in endotoxin-induced acute lung injury

T2 - Role of asymmetric dimethylarginine

AU - Sharma, Shruti

AU - Smith, Anita

AU - Kumar, Sanjiv

AU - Aggarwal, Saurabh

AU - Rehmani, Imran

AU - Snead, Connie

AU - Harmon, Cynthia

AU - Fineman, Jeffery

AU - Fulton, David J

AU - Catravas, John D.

AU - Black, Stephen Matthew

PY - 2010/5/1

Y1 - 2010/5/1

N2 - Acute lung injury (ALI) is associated with severe alterations in lung structure and function and is characterized by hypoxemia, pulmonary edema, low lung compliance and widespread capillary leakage. Asymmetric dimethylarginine (ADMA), a known cardiovascular risk factor, has been linked to endothelial dysfunction and the pathogenesis of a number of cardiovascular diseases. However, the role of ADMA in the pathogenesis of ALI is less clear. ADMA is metabolized via hydrolytic degradation to l-citrulline and dimethylamine by the enzyme, dimethylarginine dimethylaminohydrolase (DDAH). Recent studies suggest that lipopolysaccharide (LPS) markedly increases the level of ADMA and decreases DDAH activity in endothelial cells. Thus, the purpose of this study was to determine if alterations in the ADMA/DDAH pathway contribute to the development of ALI initiated by LPS-exposure in mice. Our data demonstrate that LPS exposure significantly increases ADMA levels and this correlates with a decrease in DDAH activity but not protein levels of either DDAH I or DDAH II isoforms. Further, we found that the increase in ADMA levels cause an early decrease in nitric oxide (NOx) and a significant increase in both NO synthase (NOS)-derived superoxide and total nitrated lung proteins. Finally, we found that decreasing peroxynitrite levels with either uric acid or Manganese (III) tetrakis (1-methyl-4-pyridyl) porphyrin (MnTymPyp) significantly attenuated the lung leak associated with LPS-exposure in mice suggesting a key role for protein nitration in the progression of ALI. In conclusion, this is the first study that suggests a role of the ADMA/DDAH pathway during the development of ALI in mice and that ADMA may be a novel therapeutic biomarker to ascertain the risk for development of ALI.

AB - Acute lung injury (ALI) is associated with severe alterations in lung structure and function and is characterized by hypoxemia, pulmonary edema, low lung compliance and widespread capillary leakage. Asymmetric dimethylarginine (ADMA), a known cardiovascular risk factor, has been linked to endothelial dysfunction and the pathogenesis of a number of cardiovascular diseases. However, the role of ADMA in the pathogenesis of ALI is less clear. ADMA is metabolized via hydrolytic degradation to l-citrulline and dimethylamine by the enzyme, dimethylarginine dimethylaminohydrolase (DDAH). Recent studies suggest that lipopolysaccharide (LPS) markedly increases the level of ADMA and decreases DDAH activity in endothelial cells. Thus, the purpose of this study was to determine if alterations in the ADMA/DDAH pathway contribute to the development of ALI initiated by LPS-exposure in mice. Our data demonstrate that LPS exposure significantly increases ADMA levels and this correlates with a decrease in DDAH activity but not protein levels of either DDAH I or DDAH II isoforms. Further, we found that the increase in ADMA levels cause an early decrease in nitric oxide (NOx) and a significant increase in both NO synthase (NOS)-derived superoxide and total nitrated lung proteins. Finally, we found that decreasing peroxynitrite levels with either uric acid or Manganese (III) tetrakis (1-methyl-4-pyridyl) porphyrin (MnTymPyp) significantly attenuated the lung leak associated with LPS-exposure in mice suggesting a key role for protein nitration in the progression of ALI. In conclusion, this is the first study that suggests a role of the ADMA/DDAH pathway during the development of ALI in mice and that ADMA may be a novel therapeutic biomarker to ascertain the risk for development of ALI.

KW - Arginine metabolism

KW - Nitration

KW - Superoxide

UR - http://www.scopus.com/inward/record.url?scp=77950916518&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950916518&partnerID=8YFLogxK

U2 - 10.1016/j.vph.2009.11.010

DO - 10.1016/j.vph.2009.11.010

M3 - Article

VL - 52

SP - 182

EP - 190

JO - Vascular Pharmacology

JF - Vascular Pharmacology

SN - 1537-1891

IS - 5-6

ER -